Nuclear Medicine
CLINICAL DECISION SUPPORT
| Clinical Evaluation |
|---|
| Glucose metabolism |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| B (generally recommended) |
| Level of Evidence |
| well-designed NM recommendations |
| Effective Dose |
| 19.0 µSv/MBq |
| Bibliographic Reference |
|
Salaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, Coriat R, Hindie E, Taieb D, Tabarin A, Girard A, Grellier JF, Brenot-... read moreSalaün PY, Abgral R, Malard O, Querellou-Lefranc S, Quere G, Wartski M, Coriat R, Hindie E, Taieb D, Tabarin A, Girard A, Grellier JF, Brenot-Rossi I, Groheux D, Rousseau C, Deandreis D, Alberini JL, Bodet-Milin C, Itti E, Casasnovas O, Kraeber-Bodere F, Moreau P, Philip A, Balleyguier C, Luciani A, Cachin F. Good clinical practice recommendations for the use of PET/CT in oncology. Eur J Nucl Med Mol Imaging. 2020; https://doi.org/10.1007/s00259-019-04553-8. Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N; ESMO Guidelines Committee. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018; https://doi.org/10.1093/annonc/mdy160. NCCN - cervical cancer, version 1.2021 read less |
| Guide to Nuclear Medicine |
| Read the corresponding chapter |